GENESIS

Scope & Guideline

Igniting Innovation in Cell Biology and Beyond

Introduction

Delve into the academic richness of GENESIS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1526-954x
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2000 to 2024
AbbreviationGENESIS / Genesis
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'GENESIS' focuses on the intricate biology of blood vessels and endothelial cells, emphasizing their roles in health and disease. It encompasses a broad range of research areas related to vascular biology, angiogenesis, and endothelial function, employing diverse methodologies from molecular biology to advanced imaging techniques.
  1. Vascular Biology and Angiogenesis:
    The journal extensively covers the mechanisms of vascular development and the processes of angiogenesis, including the signaling pathways and cellular interactions that govern these phenomena.
  2. Endothelial Cell Function and Dysfunction:
    Research on the normal and pathological functions of endothelial cells is a core focus, including studies on endothelial barrier integrity, inflammation, and responses to various stimuli.
  3. Molecular Mechanisms in Vascular Diseases:
    The journal highlights the molecular underpinnings of vascular diseases, such as hereditary hemorrhagic telangiectasia, diabetic retinopathy, and the effects of systemic diseases like COVID-19 on endothelial health.
  4. Innovative Therapeutic Approaches:
    There is a consistent emphasis on novel therapeutic strategies targeting the vascular system, including gene therapies, monoclonal antibodies, and small molecules aimed at modulating angiogenesis and endothelial function.
  5. Emerging Technologies in Vascular Research:
    The journal promotes studies utilizing cutting-edge technologies, such as organ-on-a-chip models, CRISPR gene editing, and advanced imaging techniques, to explore vascular biology.
Recent publications in 'GENESIS' reveal several emerging themes and trends that reflect the evolving landscape of vascular biology research. These themes indicate a shift towards understanding complex interactions and therapeutic innovations.
  1. Impact of Systemic Conditions on Endothelial Health:
    Increasing attention is being paid to how systemic diseases, particularly COVID-19, affect endothelial function, highlighting the importance of endothelial health in overall disease outcomes.
  2. Role of Extracellular Vesicles in Angiogenesis:
    Research is emerging on the role of extracellular vesicles in mediating communication between cells in the vascular niche, influencing angiogenesis and vascular remodeling.
  3. Endothelial Cell Plasticity:
    There is a growing interest in the plasticity of endothelial cells, including their ability to adapt to varying physiological and pathological conditions, which is crucial for understanding vascular responses.
  4. Therapeutic Targeting of Angiogenesis:
    A significant trend is the exploration of novel therapeutic targets within angiogenic pathways, including the development of monoclonal antibodies and small molecules aimed at specific vascular mediators.
  5. Integration of Genomics and Vascular Biology:
    The integration of genomic data with vascular biology is becoming increasingly prominent, with studies focusing on genetic predispositions to vascular diseases and the implications of genetic mutations on endothelial function.

Declining or Waning

While the journal continues to grow in many areas, some themes appear to be declining in prominence. This shift may reflect changing research priorities or the maturation of certain lines of inquiry.
  1. Traditional Angiogenesis Models:
    There is a noticeable reduction in studies utilizing classical in vitro models of angiogenesis, such as Matrigel assays, as researchers increasingly turn to more sophisticated systems that better mimic physiological conditions.
  2. Basic Vascular Anatomy Studies:
    Research focused solely on the descriptive aspects of vascular anatomy without functional implications is becoming less frequent, as the field moves towards understanding the dynamic processes involved in vascular function and pathology.
  3. Isolated Disease Studies:
    There is a waning interest in studies that focus exclusively on single diseases without considering the broader implications on vascular biology, as integrated approaches are gaining favor.

Similar Journals

CELL BIOLOGY INTERNATIONAL

Shaping the Future of Cell Biology and Medicine
Publisher: WILEYISSN: 1065-6995Frequency: 12 issues/year

CELL BIOLOGY INTERNATIONAL is a prestigious academic journal dedicated to the rapidly evolving field of cell biology, publishing high-quality research aimed at understanding cellular processes and their implications in various biological contexts. Published by Wiley, this journal has established its relevance with an H-Index that reflects its robust citation impact and a commendable Scopus Rank of #111 out of 285 in the field of Biochemistry, Genetics, and Molecular Biology, positioning it in the 61st percentile. Although it operates under a traditional subscription model, its influential insights are crucial for researchers, professionals, and students alike who are seeking cutting-edge developments in cellular mechanisms and their applications in medicine. The journal spans contributions dating back to 1993, providing a rich archive of knowledge that continues to shape the discourse within the scientific community. With a strong category ranking of Q3 in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, CELL BIOLOGY INTERNATIONAL stands as a reliable platform for disseminating transformative science in the cellular domain.

MOLECULAR AND CELLULAR PROBES

Fostering Innovation in Biochemistry and Genetics
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0890-8508Frequency: 6 issues/year

MOLECULAR AND CELLULAR PROBES, published by Academic Press Ltd - Elsevier Science Ltd, stands as a prominent journal at the intersection of cell and molecular biology. With an ISSN of 0890-8508 and an E-ISSN of 1096-1194, this journal has consistently contributed to the scientific discourse since its inception in 1987, converging its scholarly content through to 2024. As a member of Q3 in both Cell Biology and Molecular Biology categories, it provides a platform for innovative research and critical insights into cellular mechanisms, signaling pathways, and molecular interactions. Its Scopus rankings position it within the top half of its categories, fostering a vibrant academic community that supports the exploration and advancement of biochemistry, genetics, and molecular biology. Although it does not currently offer Open Access, the high-quality peer-reviewed articles published in MOLECULAR AND CELLULAR PROBES are invaluable resources for researchers, professionals, and students who seek to stay at the forefront of breakthroughs in these essential fields.

EXPERIMENTAL EYE RESEARCH

Transforming Understanding of Vision Through Rigorous Research
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0014-4835Frequency: 12 issues/year

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

Cell Discovery

Exploring the Depths of Biochemistry and Genetics
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

CELL RESEARCH

Advancing the Frontiers of Cell Biology
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

JOURNAL OF BIOLOGICAL CHEMISTRY

Shaping the Future of Biological Sciences
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

JOURNAL OF BIOLOGICAL CHEMISTRY, published by Elsevier, is a premier interdisciplinary journal dedicated to advancing our understanding of biochemistry, cell biology, and molecular biology. With a prestigious history dating back to 1945 and an impressive convergence of research expected to continue through 2024, this journal holds a Q1 ranking in all three of its core categories, signaling its critical influence in the respective fields, supported by a robust Scopus ranking that places it among the top echelons of internationally recognized research. Although currently not available as Open Access, the journal is essential for researchers and professionals looking to stay abreast of the latest breakthroughs and innovations in biochemical research. With a deep commitment to scientific rigor and a focus on diverse topics ranging from cellular processes to molecular mechanisms, the Journal of Biological Chemistry serves as a vital resource for the academic community, shaping the future of biological sciences.

ANGIOGENESIS

Advancing Knowledge in Tumor Biology and Tissue Regeneration
Publisher: SPRINGERISSN: 0969-6970Frequency: 4 issues/year

ANGIOGENESIS is a prestigious academic journal published by Springer, focusing on the vital field of angiogenesis research, a cornerstone in understanding tumor biology and tissue regeneration. Established in 1997 and continuously evolving, this journal has solidified its reputation, ranking in the Q1 category for Cancer Research, Clinical Biochemistry, and Physiology as of 2023. With an impressive impact factor, it serves as an essential platform for disseminating cutting-edge research findings, critical reviews, and novel methodologies. ANGIOGENESIS is indexed in high-impact databases and exhibits exceptional Scopus ranks—1st in Clinical Biochemistry, 6th in Physiology, and 14th in Cancer Research, underscoring its significant contribution to the scientific community. Although it does not currently offer open access options, it ensures that all articles maintain rigorous peer-review standards to meet the highest academic excellence. Researchers, professionals, and students alike will find ANGIOGENESIS to be an invaluable resource in advancing their knowledge and research in the intricate mechanisms of vascular biology.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Unraveling the Mysteries of Molecular Biology
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

JOURNAL OF GENE MEDICINE

Elevating Standards in Gene Medicine Research
Publisher: WILEYISSN: 1099-498XFrequency: 12 issues/year

The Journal of Gene Medicine, published by Wiley, stands as a pivotal resource in the field of gene therapy and molecular medicine, with a rich history of dissemination of impactful research since its inception in 1998. With an ISSN of 1099-498X and an E-ISSN of 1521-2254, this esteemed journal plays a crucial role in advancing our understanding of genetics and drug discovery, reflected in its impressive 2023 Scopus rankings where it holds a Q2 classification in Drug Discovery and Q3 in several genetics-related categories. The journal aims to facilitate the exchange of high-quality research findings that bridge the gap between laboratory and clinical applications, making it an essential platform for researchers, academics, and healthcare professionals committed to the forefront of genetic innovation. Although it does not currently offer open access options, its reputation for rigorous peer review ensures that all published work meets the highest academic standards, providing a reliable reference for scientific inquiry in the United States and beyond. As the field rapidly evolves, the Journal of Gene Medicine remains at the helm, guiding future discoveries with its influential publications and comprehensive insights.

Journal of Molecular Cell Biology

Innovating research in molecular biology and genetics.
Publisher: OXFORD UNIV PRESSISSN: 1674-2788Frequency: 6 issues/year

The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.